Asset
DANICAMTIV
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07210723 | phase2_3 | recruiting | 2026-02-13 | 2027-09-01 | Kardigan, Inc. | A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy |
| NCT07771465 | phase3 | recruiting | 2026-08-26 | 2032-11-01 | Kardigan, Inc. | A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy |
FDA applications (0)
This company has no applications containing this asset.